The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa

Ann N Y Acad Sci. 2000 Nov:918:53-6. doi: 10.1111/j.1749-6632.2000.tb05473.x.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acquired Immunodeficiency Syndrome / economics
  • Acquired Immunodeficiency Syndrome / prevention & control*
  • Acquired Immunodeficiency Syndrome / transmission*
  • Africa South of the Sahara
  • Anti-HIV Agents / economics
  • Anti-HIV Agents / therapeutic use*
  • Computer Simulation
  • Cost-Benefit Analysis
  • Female
  • HIV Seroprevalence
  • HIV-1
  • Humans
  • Infant
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Models, Statistical
  • Mothers
  • Nevirapine / economics
  • Nevirapine / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Complications, Infectious / economics
  • Pregnancy Complications, Infectious / prevention & control
  • Uganda

Substances

  • Anti-HIV Agents
  • Nevirapine